Navigation Links
BioMed Realty Trust Announces Tax Treatment of 2008 Distributions
Date:1/20/2009

SAN DIEGO, Jan. 20 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2008 distributions as follows:

                   Security Description: Common Stock
                          CUSIP: 09063H107
                         Ticker Symbol: BMR

                                    Total                    Taxable
       Record       Payable     Distribution   Allocable     Ordinary
        Date         Date         Per Share     to 2008      Dividend

     12/31/2007    1/15/2008      $0.310000    $0.310000     $0.198099
      3/31/2008    4/15/2008      $0.335000    $0.335000     $0.214074
      6/30/2008    7/15/2008      $0.335000    $0.335000     $0.214074
      9/30/2008    10/15/2008     $0.335000    $0.335000     $0.214074
             Totals               $1.315000    $1.315000     $0.840321


                                              Long-Term    Unrecaptured
      Record       Payable       Return of     Capital     Section 1250
       Date          Date         Capital        Gain          Gain

     12/31/2007    1/15/2008     $0.111901     $0.000000     $0.000000
      3/31/2008    4/15/2008     $0.120926     $0.000000     $0.000000
      6/30/2008    7/15/2008     $0.120926     $0.000000     $0.000000
      9/30/2008    10/15/2008    $0.120926     $0.000000     $0.000000
             Totals              $0.474679     $0.000000     $0.000000


        Security Description: 7.375% Series A Cumulative Redeemable
                             Preferred Stock
                              CUSIP: 09063H206
                          Ticker Symbol: BMR PR A

                                   Total                Taxable
       Record       Payable    Distribution  Allocable  Ordinary
        Date         Date        Per Share    to 2008   Dividend

     12/31/2007    1/15/2008     $0.460940   $0.460940   $0.460940
      3/31/2008    4/15/2008     $0.460940   $0.460940   $0.460940
      6/30/2008    7/15/2008     $0.460940   $0.460940   $0.460940
      9/30/2008    10/15/2008    $0.460940   $0.460940   $0.460940
             Totals               $1.84376    $1.84376    $1.84376


                                            Long-Term   Unrecaptured
       Record      Payable      Return of     Capital   Section 1250
        Date         Date         Capital      Gain        Gain

     12/31/2007    1/15/2008     $0.000000   $0.000000   $0.000000
      3/31/2008    4/15/2008     $0.000000   $0.000000   $0.000000
      6/30/2008    7/15/2008     $0.000000   $0.000000   $0.000000
      9/30/2008    10/15/2008    $0.000000   $0.000000   $0.000000
             Totals              $0.000000   $0.000000   $0.000000


The distributions payable on January 15, 2009 to shareholders of record on December 31, 2008, as previously announced on December 15, 2008, are considered 2009 distributions for federal income tax purposes.

The company did not incur any foreign taxes during 2008. In addition, only for purposes of calculating alternative minimum taxable income under Section 55 of the Internal Revenue Code of 1986, as amended, the company apportions $0.0009 per common share and Series A preferred share attributable to depreciation, each assuming a full year of ownership. Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 69 properties, representing 112 buildings with approximately 10.4 million rentable square feet, including approximately 1.4 million square feet of development in progress. The company also owns undeveloped land parcels adjacent to existing properties that it estimates can support up to 1.4 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.


'/>"/>
SOURCE BioMed Realty Trust, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alpine Biomed Acquires Stellate to Create New Leader in Neurology Diagnostics Market
2. BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer
3. Collexis BiomedExperts Hits 80,000 Registered Users Within the First Year!
4. 5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
5. Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference
6. Response Biomedical Corporation Announces Change of Executives
7. AutismActionPlan.org Launches Doctor-Driven Biomedical Autism Treatment Website
8. LA BioMed researchers among Southern California Super Doctors
9. ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
10. ASH Honors Speaker of the House Nancy Pelosi and NHLBI Deputy Director Susan Shurin, MD, for Their Public Service, Leadership, and Commitment to Biomedical Research
11. Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect Plugin ... whole new perspective by using the title layers in ProSlice Levels to split-up ... Levels contains over 30 Different presets to choose from. FCPX users can ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: